Trinity Biotech reported $100.76M in Debt for its fiscal quarter ending in December of 2024.


Debt Change Date
Abbott USD 13.44B 195M Jun/2025
Bayer EUR 39.39B 1.31B Mar/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
EDAP TMS EUR 13.92M 10.12M Dec/2024
J&J USD 52.25B 15.62B Mar/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Siemens EUR 57.52B 7.64B Mar/2025
Thermo Fisher Scientific USD 34.19B 2.91B Mar/2025
Tosoh JPY 179.1B 25.51B Mar/2025
Trinity Biotech USD 100.76M 7.05M Dec/2024
Veracyte USD 50.5M 50.5M Mar/2025